- Home
- INBS vs XAIR Comparison
INBS vs XAIR Comparison
Compare INBS & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INBS | XAIR |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7M | 5.4M |
| IPO Year | 2019 | 2015 |
Fundamental Metrics
Financial Performance| Metric | INBS | XAIR |
|---|---|---|
| Price | $2.61 | $0.50 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 75.3K | ★ 343.5K |
| Earning Date | 05-12-2026 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 68.65 | 62.09 |
| EPS | N/A | ★ N/A |
| Revenue | $1,980,484.00 | ★ $3,705,000.00 |
| Revenue This Year | $778.48 | $122.00 |
| Revenue Next Year | N/A | $58.15 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 219.67 |
| 52 Week Low | $0.54 | $0.15 |
| 52 Week High | $24.90 | $3.78 |
Technical Indicators
Market Signals| Indicator | INBS | XAIR |
|---|---|---|
| Relative Strength Index (RSI) | 35.94 | 33.88 |
| Support Level | $2.42 | $0.43 |
| Resistance Level | $7.25 | $0.82 |
| Average True Range (ATR) | 0.23 | 0.07 |
| MACD | 0.07 | -0.00 |
| Stochastic Oscillator | 20.27 | 15.09 |
Price Performance
Historical ComparisonAbout INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.